Condensed Consolidated Changes in Stockholders' Deficit (Unaudited) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated other comprehensive loss
Balance, shares at Dec. 31, 2019			62,410,452
Balance, amount at Dec. 31, 2019	$ (35,744)	$ 0	$ 6,241	$ (6,241)	$ (35,744)
Net Loss	(709)	0	$ 0	0	(709)
Balance, shares at Mar. 31, 2020			62,410,452
Balance, amount at Mar. 31, 2020	(36,453)	0	$ 6,241	(6,241)	(36,453)
Balance, shares at Dec. 31, 2019			62,410,452
Balance, amount at Dec. 31, 2019	(35,744)	0	$ 6,241	(6,241)	(35,744)
Net Loss	72,872
Balance, shares at Sep. 30, 2020			62,410,452
Balance, amount at Sep. 30, 2020	37,128	0	$ 6,241	(6,241)	37,128
Balance, shares at Mar. 31, 2020			62,410,452
Balance, amount at Mar. 31, 2020	(36,453)	0	$ 6,241	(6,241)	(36,453)
Net Loss	(186)	0	$ 0	0	(186)
Balance, shares at Jun. 30, 2020			62,410,452
Balance, amount at Jun. 30, 2020	(36,639)	0	$ 6,241	(6,241)	(36,639)
Net Loss	73,767	0	$ 0	0	73,767
Balance, shares at Sep. 30, 2020			62,410,452
Balance, amount at Sep. 30, 2020	37,128	0	$ 6,241	(6,241)	$ 37,128
Balance, shares at Dec. 31, 2020			62,410,452
Balance, amount at Dec. 31, 2020	11,250	0	$ 6,241	416		$ 4,593
Net Loss	(66,551)	0	0	0		(66,551)
Accretion of stock-based compensation	10,433	0	$ 0	10,433		0
Balance, shares at Mar. 31, 2021			62,410,452
Balance, amount at Mar. 31, 2021	(44,868)	0	$ 6,241	10,849		(61,958)
Balance, shares at Dec. 31, 2020			62,410,452
Balance, amount at Dec. 31, 2020	11,250	$ 0	$ 6,241	416		4,593
Net Loss	(2,492,817)
Balance, shares at Sep. 30, 2021		27,272	122,817,746
Balance, amount at Sep. 30, 2021	7,880,811	$ 3	$ 12,281	10,356,751		(2,488,224)
Balance, shares at Mar. 31, 2021			62,410,452
Balance, amount at Mar. 31, 2021	(44,868)	0	$ 6,241	10,849		(61,958)
Net Loss	(1,874,307)	0	0	0		(1,874,307)
Accretion of stock-based compensation	15,134	0	0	15,134		0
Issuance of stock warrants for development of product	(1,399,833)	0	$ 0	1,399,833		0
Recapitalization of the Company, shares			33,203,512
Recapitalization of the Company, amount	(84,225)	$ 0	$ 3,320	(87,545)		0
Series D preferred stock issued for cash and settlement of accounts payable, shares		440,125
Series D preferred stock issued for cash and settlement of accounts payable, amount	6,601,745	$ 44	$ 0	6,601,701		0
Exercised option and warrants, shares			1,175,500
Exercised option and warrants, amount	150,345	0	$ 118	150,227		0
Issuance of common stock for license rights, shares			1,602,282
Issuance of common stock for license rights, amount	1,073,529	$ 0	$ 160	1,073,369		0
Balance, shares at Jun. 30, 2021		440,125	98,391,746
Balance, amount at Jun. 30, 2021	7,237,186	$ 44	$ 9,839	9,163,568		(1,936,265)
Net Loss	(551,959)	0	0	0		(551,959)
Accretion of stock-based compensation	60,585	0	$ 0	60,585
Exercised option and warrants, shares			3,783,333
Exercised option and warrants, amount	1,134,999	$ 0	$ 377	1,134,622		0
Conversion of convertible preferred shares into common stock, shares		(412,853)	20,642,667
Conversion of convertible preferred shares into common stock, amount	0	$ (41)	$ 2,064	(2,023)		0
Balance, shares at Sep. 30, 2021		27,272	122,817,746
Balance, amount at Sep. 30, 2021	$ 7,880,811	$ 3	$ 12,281	$ 10,356,751		$ (2,488,224)